News

HDA Media And Political Bulletin – 12 October 2016

European medicines regulator sets out plans for revamped drug database

11 October 2016, The Pharmaceutical Journal

 

The European Medicines Agency (EMA) have approved plans for a new electronic database to replace EudraPharm11. It will contain information about all human medicines authorised for use across Europe. The information included on this database will be accessible to the general public as well as healthcare professions. This announcement follows the European pharmacovigilance legislation requiring the creation of an accessible database as part of the EMA’s work to protect public health.

Parliamentary Coverage

 

There is no parliamentary coverage today.

 

Full Coverage

European medicines regulator sets out plans for revamped drug database

11 October 2016, The Pharmaceutical Journal

 

Plans for an electronic database containing information about all human medicines authorised across Europe, which will be accessible to the public as well as healthcare professionals, have been approved by the European Medicines Agency (EMA).

The medicines safety regulator announced on 7 October 2016 that it has agreed the first steps in developing the web portal, which follows European pharmacovigilance legislation requiring the creation of an accessible database, as part of the EMA’s work to protect public health.

As a starting point, the site will contain all the product data provided to the EMA by drug manufacturers as part of the statutory regulatory process. It will also provide links to similar data held by EU member states’ own national medicines safety regulators.

In a paper adopted by the EMA’s management board on 6 October 2016, the EMA explains that the database, which will be multilingual with search and browse options, will be supplemented with additional validated information as it becomes available.

“The vision for the European medicines web portal is to launch a multilingual website for patients and healthcare professionals, as well as other groups or individuals looking for information and data on medicines, such as academic researchers, providing access to information on nationally and centrally authorised medicines for human use in the EU,” the EMA states, adding that the initiative will enhance the reputation of European medicines regulators as providers of “unbiased, up-to-date, trustworthy, scientifically sound and validated online information on medicines”.

The new website will replace EudraPharm11, a website developed by the EMA in 2006 that sought to provide access to information on medicines authorised in the EU.

HDA Media And Political Bulletin – 12 October 2016

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?